S2

Select Medical Holdings CorpFRA Select Medical Stock Report

Last reporting period 30 Sep, 2024

Updated 12 Nov, 2024

Last price

Market cap $B

4.6

Middle

Exchange

XFRA - Deutsche Boerse AG

S24.F Stock Analysis

S2

Avoid

Based on Eyestock quantitative analysis, S24.F`s fundamental data and valuation indicate an investment grade of Avoid at the current time.

Rating

To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.

47/100

Low score

Upside

To determine whether the current price is a reasonable to buy a stock, we compare it to our estimate of fair value. The more undervalued a stock is, the higher the upside.

-11.7 %

Overvalued

Market cap $B

4.6

Dividend yield

1.51 %

Shares outstanding

127.17 B

Select Medical Holdings Corp. engages in the provision of medical rehabilitation services. The company is headquartered in Mechanicsburg, Pennsylvania and currently employs 37,800 full-time employees. The company went IPO on 2009-09-25. The firm operates through four business segments: Critical Illness Recovery Hospital, which consists of hospitals that serves the needs of patients recovering from critical illnesses; Rehabilitation Hospital, which consists of hospitals that serves patients that require intensive physical rehabilitation care; Outpatient Rehabilitation, which consists of clinics that provide physical, occupational, and speech rehabilitation services, and Concentra, which consists of occupational health centers that provides workers’ compensation injury care, physical therapy, and consumer health services and onsite clinics. The company operates approximately 103 critical illness recovery hospitals in 28 states, 31 rehabilitation hospitals in 12 states, and over 1,928 outpatient rehabilitation clinics in 39 states.

View Section: Eyestock Rating